Forever Labs spun out SuperShot Inc. as an independent company and appointed Kevin Virgil CEO of Forever Labs; the founders moved to lead SuperShot.
SourceWe bank your stem cells to help you live healthier, longer.
Public company, workplace, funding, and market signals
Forever Labs is a regenerative medicine and longevity company that banks and cryopreserves a patient’s own adult stem cells for future autologous therapies, working through a board-certified physician network and ISO-accredited biobanking.
Primary product
Adult stem cell banking and future stem-cell expansion services
Founded
2015
Headquarters
Ann Arbor, Michigan, United States
Team size
1-10 employees
Work style
Onsite
Industry
Biotechnology Research
Sub-industry
Stem cell banking and regenerative medicine
Offices
0 jobs at Forever Labs
Check back later for new openings
Business model
Stage
Seed
Total raised
$3.5M
Latest round
Seed · May 2018
Latest amount
$2M
Leadership
CEO
Chief Marketing Officer
Laboratory Director
Chief Medical Officer
Mark Katakowski, PhD
Co-Founder & Chief Scientific Officer
Investors
Science-first and evidence-based, with recurring company messaging that emphasizes following the science, not the hype. The team appears mission-driven around longevity and regenerative medicine, with close collaboration between clinicians, providers, and biobank operations.
Work style
Onsite
Pricing
Membership / annual storage subscription with a lifetime prepaid option; discounted procedure-specific plans for orthopedic and aesthetic partner-clinic referrals.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$1M-$10M
Forever Labs spun out SuperShot Inc. as an independent company and appointed Kevin Virgil CEO of Forever Labs; the founders moved to lead SuperShot.
SourcePR Newswire · Jun 2026
Announced a partnership to combine AcCELLerated Biologics’ distribution with Forever Labs’ stem-cell collection, storage, and planned expansion services, with initial focus on physician education and Florida clinics.
Forever Labs blog · Apr 2026
Announced a partnership to capture adipose tissue from aesthetic procedures and bank stem cells for future use, including regenerative and orthopedic applications.
Forever Labs blog · Mar 2026
Covers a webinar with the Michigan Center for Regenerative Medicine and describes Forever Labs’ upcoming culture-expansion lab as a way to increase cell dose for future therapies.
Forever Labs blog · Jan 2026
Explains the company’s view of shifting state-level regulatory frameworks, expanding domestic manufacturing, and its planned culture-expansion facility in Jupiter, Florida.
PR Newswire · May 2025
Forever Labs spun out SuperShot Inc. as an independent company and named Kevin Virgil CEO of Forever Labs. The founders shifted to lead SuperShot while Forever Labs continued stem-cell preservation and therapeutics.